Study Summary
This trial will help researchers understand how best to treat femoral metastases, specifically those at high risk of pathological fracture.
- Metastatic Bone Cancer
- Risk of Fracture
- Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: 6 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Surgery Alone
1 of 2
Surgery + Radiation Therapy
1 of 2
Active Control
180 Total Participants · 2 Treatment Groups
Primary Treatment: Surgery Alone · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How many participants have registered for this clinical trial?
"Absolutely. According to the clinicaltrials.gov listing, this study initiated recruitment on March 1st 2009 and has been recently updated as of October 6th 2022. This medical trial is currently requesting 180 patients for participation at two separate sites." - Anonymous Online Contributor
Are new participants still eligible to join this research experiment?
"Indeed, clinicaltrials.gov confirms that this medical trial remains open to applicants. Originally posted on March 1st 2009 and updated October 6th 2022, the study is targeting 180 patients across two research centres." - Anonymous Online Contributor